Document is current
Any future updates will be listed below
-
Authors
Luke, Jason J https://orcid.org/0000-0002-1182-4908
Pinato, David J https://orcid.org/0000-0002-3529-0103
Juric, Dejan
LoRusso, Patricia
Hosein, Peter J
Desai, Anupam M
Haddad, Robert https://orcid.org/0000-0003-1413-0079
de Miguel, María
Cervantes, Andrés https://orcid.org/0000-0003-3806-3691
Kim, Won Seog
Marabelle, Aurélien https://orcid.org/0000-0002-5816-3019
Zhang, Yan
Rong, Yuanxin
Yuan, Xiaobin https://orcid.org/0009-0003-8389-6059
Champiat, Stéphane
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04144140 at ClinicalTrials.govDocuments that mention this clinical trial
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors
https://doi.org/10.1136/jitc-2024-010511
Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer
https://doi.org/10.1136/jitc-2022-006170
-
Funding
Funding for this research was provided by:
Eisai Inc. (N/A)
- License Information
